Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization

OBJECTIVE: To investigative whether the odds tumor enhancement ratio (OTER) on cross-sectional imaging is a prognostic factor for hepatocellular carcinoma after transarterial chemoembolization (TACE). METHODS: This study involved 126 patients who underwent TACE from May 2015 to March 2019. The signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xi-Yuan, Deng, Jiang-Bei, An, Tian-Zhi, Zhou, Shi, Li, Jun-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647277/
https://www.ncbi.nlm.nih.gov/pubmed/34812068
http://dx.doi.org/10.1177/03000605211058367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647277/
https://www.ncbi.nlm.nih.gov/pubmed/34812068
http://dx.doi.org/10.1177/03000605211058367

Ejemplares similares